Ultragenyx Pharmaceutical reported $86.98M in Sales Revenues for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Sales Change
Acadia Pharmaceuticals ACAD:US $ 115.22M 8.67M
Acceleron Pharma XLRN:US $ 27.94M 3.18M
Alexion Pharmaceuticals ALXN:US $ 1636.5M 44.7M
Alnylam Pharmaceuticals ALNY:US $ 220.55M 42.99M
Aptinyx Inc APTX:US $ 0 1000K
Biocryst Pharmaceuticals BCRX:US $ 49.96M 30.9M
Biomarin Pharmaceutical BMRN:US $ 501.69M 15.66M
Bluebird Bio BLUE:US $ 7.47M 5.32M
Epizyme EPZM:US $ 13.01M 5.38M
Esperion Therapeutics ESPR:US $ 40.66M 32.68M
Gw Pharmaceuticals GWPH:US $ 152.47M 4.24M
Insmed INSM:US $ 45.37M 5.15M
IONIS PHARMACEUT IONS:US $ 125.75M 14.14M
Karyopharm Therapeutics KPTI:US $ 22.6M 659K
Kyowa Hakko Kirin 4151:JP Y 83906M 2791M
Macrogenics MGNX:US $ 30.76M 13.88M
Mirati Therapeutics MRTX:US $ 0M 0M
Moderna Inc MRNA:US 4.35B 2.42B
Neurocrine Biosciences NBIX:US $ 288.9M 52.3M
Ptc Therapeutics PTCT:US $ 116.68M 1.27M
Puma Biotechnology PBYI:US $ 53.38M 44.78M
Regeneron Pharmaceuticals REGN:US $ 5138.5M 2609.8M
Sarepta Therapeutics SRPT:US $ 164.09M 17.16M
Ultragenyx Pharmaceutical RARE:US $ 86.98M 12.42M
Vertex Pharmaceuticals VRTX:US $ 1793.37M 69.06M
Xoma XOMA:US $ 901K 526K